Search found 24 item(s)
Posted on: August 23, 2014 -
Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits
Article published in The Lancet on 05-Nov-1994 by Sanchez JL et al. ABSTRACT: The cholera epidemic in South America has reinforced the need for safe and effective oral vaccines. In a randomised, double-blind, placebo-controlled efficacy trial among 1563 ...
Posted on: August 23, 2014 -
Article published in The Lancet on 03-Feb-1990 by Clemens JD et al. ABSTRACT: The protective efficacy (PE) of B subunit killed whole-cell (BS-WC) and killed whole-cell-only (WC) oral cholera vaccines was assessed in a randomised double-blind field trial ...
Posted on: July 8, 2014 -
Cholera is one of the most feared diseases and many people die of the disease each year. The disease was first noted by British troops near Jessore, India in 1817. By 1832, it had spread across ...
Posted on: July 1, 2014 - Journal articles
Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India
Article published by PLOS One on 1-July-2014 by Kanungo S. et al. ABSTRACT Background: A live oral cholera vaccine VA 1.4 developed from a non-toxigenic Vibrio cholerae O1 El Tor strain using ctxB gene insertion was further developed into a clinical ...
Posted on: May 1, 2014 - Journal articles
Immunogenicity of a Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine, Shanchol, in Haiti
Article published in PLOS Neglected Tropical Diseases on 01-May-2014 by Charles RC. et al. ABSTRACT Background:Studies of the immunogenicity of the killed bivalent whole cell oral cholera vaccine, Shanchol, have been performed in historically cholera ...
Posted on: October 17, 2013 - Journal articles
5 Year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: A cluster-randomised, double-blind, placebo-controlled trial
Article published in The Lancet on 17-Oct-2013 by Bhattacharya, S. K. et al. BACKGROUND: Efficacy and safety of a two-dose regimen of bivalent killed whole-cell oral cholera vaccine (Shantha Biotechnics, Hyderabad, India) to 3 years is established, but ...
Posted on: October 29, 2012 - Journal articles
Article published by Human Vaccines & Immunotherapeutics 29-October-2012 by Lopez-Gigosos et al. ABSTRACT Objective: Traveler’s diarrhea (TD) is the most frequent disease among people from industrialized countries who travel to less developed ones, ...
Posted on: September 4, 2012 - Journal articles
Effectiveness of an oral cholera vaccine in Zanzibar: Findings from a mass vaccination campaign and observational cohort study
Article published in The Lancet Infectious Diseases on 4-Sep-2012 by Khatib, A. M. et al. BACKGROUND: Zanzibar, in east Africa, has been severely and repeatedly affected by cholera since 1978. We assessed the effectiveness of oral cholera vaccination in ...
Posted on: August 1, 2012 - Journal articles
Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera
Article published in Clinical and Vaccine Immunology in August 2012 by Arifuzzaman M. et al. ABSTRACT Young children, older children, and adults develop comparable levels and durations of immunity following cholera. In comparison, young children receiving ...
Posted on: July 24, 2012 - Journal articles
Safety of the Recombinant Cholera Toxin B Subunit, Killed Whole-Cell (rBS-WC) Oral Cholera Vaccine in Pregnancy
Article published in PLOS Neglected Tropical Diseases on 24-July-2012 by Hashim R. et al ABSTRACT Introduction: Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of ...